Literature DB >> 467482

Comparative effects of nifedipine, verapamil, isosorbide dinitrate and propranolol on exercise-induced angina pectoris.

C de Ponti, F Mauri, G R Ciliberto, B Carù.   

Abstract

According to the experimental model of a 5 X 5 Latin square, 5 treatments were studied single blind in 5 patients, affected by stable-effort angina, by means of exercise tests. In the period of maximal supposed effect the following treatments were investigated: placebo (P), 1 tablet, orally; isosorbide dinitrate (ISDN), 5 mg, sublingually; propranolol (Pr), 40 mg, orally; nifedipine (N), 10 mg, orally; verapamil (V), 160 mg, orally. Placebo, compared with its own control tests, did not change any of the examined parameters. Comparison of the 'active' treatments with P showed the following results. All the treatments increased the duration of work before ECG positivity appearances. An increase in duration of work and total work performed before angina was seen after administration of ISIDN, N and V; the improvement observed after treatment with Pr was not significant. Comparison of treatments showed that work performance before angina was the same after administration of ISDN, N and V; these treatments were more effective than that with 40 mg Pr. Duration of work before ECG positivity was significantly longer after ISDN and N than after Pr. The changes in heart rate, maximal arterial pressure, ejection time index and triple product confirmed the activity of the administered doses. According to the observed effects on exercise tolerance, in comparison with P the same level of work was performed with the same triple product after Pr, and with lower triple products after ISDN, N and V.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 467482

Source DB:  PubMed          Journal:  Eur J Cardiol        ISSN: 0301-4711


  7 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris.

Authors:  M Picca; F Azzollini; A Cereda; G Pelosi
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Calcium antagonists and the heart.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-10

Review 4.  Calcium antagonists. Clinical use in the treatment of angina.

Authors:  P Théroux; Y Taeymans; D D Waters
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

5.  Calcium antagonist drugs in chronic stable angina. Comparison of verapamil and nifedipine.

Authors:  J R Dawson; N H Whitaker; G C Sutton
Journal:  Br Heart J       Date:  1981-11

6.  The combination of nifedipine and propranolol in the management of patients with angina pectoris.

Authors:  A C Tweddel; J M Beattie; R G Murray; I Hutton
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

7.  Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination.

Authors:  P Lynch; H Dargie; S Krikler; D Krikler
Journal:  Br Med J       Date:  1980-07-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.